BNTC |
Benitec Biopharma Inc. |
Common Stock, par value $0.0001 |
49.9% |
$208M |
|
15.6M |
|
SUVRETTA CAPITAL MANAGEMENT, LLC |
Mar 26, 2025 |
AADI |
Aadi Bioscience, Inc. |
Common Stock, par value $0.0001 per share |
9.99% |
$9.36M |
|
4.73M |
|
SUVRETTA CAPITAL MANAGEMENT, LLC |
Mar 4, 2025 |
DBVT |
DBV Technologies S.A. |
Ordinary shares, nominal value 0.10 euro per share |
9.9% |
$79.8M |
|
15.2M |
|
SUVRETTA CAPITAL MANAGEMENT, LLC |
Apr 7, 2025 |
PVLA |
Palvella Therapeutics, Inc. |
Common stock, $0.001 par value per share |
8.6% |
$20.7M |
|
714K |
|
SUVRETTA CAPITAL MANAGEMENT, LLC |
Dec 13, 2024 |
ETNB |
89bio, Inc. |
Common Stock, par value $0.001 per share |
8.5% |
$72.9M |
|
10.2M |
|
SUVRETTA CAPITAL MANAGEMENT, LLC |
Dec 31, 2024 |
KURA |
Kura Oncology, Inc. |
Common Stock, par value $0.0001 per share |
6.7% |
$40.1M |
|
5.2M |
|
SUVRETTA CAPITAL MANAGEMENT, LLC |
Dec 31, 2024 |
IMTX |
Immatics N.V. |
ordinary shares, nominal value (euro)0.01 per share |
6.5% |
$35.9M |
|
7.88M |
|
SUVRETTA CAPITAL MANAGEMENT, LLC |
Feb 4, 2025 |
FULC |
Fulcrum Therapeutics, Inc. |
Common Stock, par value $0.001 per share |
6.3% |
$13.1M |
|
3.4M |
|
SUVRETTA CAPITAL MANAGEMENT, LLC |
Dec 27, 2024 |
AURA |
Aura Biosciences, Inc. |
Common Stock, par value $0.00001 per share |
6.1% |
$22.2M |
|
3.06M |
|
SUVRETTA CAPITAL MANAGEMENT, LLC |
Apr 4, 2025 |
GLUE |
Monte Rosa Therapeutics, Inc. |
Common stock, par value $0.0001 per share |
5.5% |
$17.7M |
|
3.36M |
|
SUVRETTA CAPITAL MANAGEMENT, LLC |
Apr 9, 2025 |
MRNS |
Marinus Pharmaceuticals, Inc. |
Common Stock, par value $0.001 per share |
5.5% |
$1.66M |
|
3.02M |
|
SUVRETTA CAPITAL MANAGEMENT, LLC |
Feb 7, 2025 |
PEPG |
PepGen Inc. |
Common Stock, par value $0.0001 per share |
5.1% |
$3.74M |
|
1.66M |
|
Suvretta Capital Management, LLC |
Feb 5, 2025 |
ERAS |
Erasca, Inc. |
Common Stock, $0.0001 par value per share |
4.4% |
$18.1M |
|
12.3M |
|
SUVRETTA CAPITAL MANAGEMENT, LLC |
Dec 31, 2024 |